CLINICAL_TRIALS
trial_result
· 2017-05-05
Clinical Trial Update: Divided Dose of TRAVATAN® [Phase 2]
Summary
Phase 2 trial evaluating divided dosing of TRAVATAN for open-angle glaucoma and ocular hypertension has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alcon Research | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED